anmelden
FTSE All-Share
5.866,59
PKT
-2,70
PKT
-0,05
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.03.21 | Barclays buy | Goldman Sachs Group Inc. | |
| 11.03.21 | HSBC Underweight | JP Morgan Chase & Co. | |
| 11.03.21 | Prudential Outperform | RBC Capital Markets | |
| 11.03.21 | GSK Sell | Deutsche Bank AG | |
| 11.03.21 | Vodafone Group overweight | JP Morgan Chase & Co. | |
| 11.03.21 | National Grid Neutral | Goldman Sachs Group Inc. | |
| 10.03.21 | Prudential buy | UBS AG | |
| 10.03.21 | Shell (ex Royal Dutch Shell) overweight | JP Morgan Chase & Co. | |
| 10.03.21 | BP overweight | JP Morgan Chase & Co. | |
| 09.03.21 | National Grid Outperform | RBC Capital Markets | |
| 09.03.21 | ITV overweight | JP Morgan Chase & Co. | |
| 09.03.21 | Prudential buy | Jefferies & Company Inc. | |
| 08.03.21 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.03.21 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
| 08.03.21 | London Stock Exchange (LSE) Outperform | Credit Suisse Group | |
| 08.03.21 | AstraZeneca kaufen | Barclays Capital | |
| 08.03.21 | London Stock Exchange (LSE) Hold | Deutsche Bank AG | |
| 05.03.21 | HSBC Neutral | UBS AG | |
| 05.03.21 | BT Group overweight | Barclays Capital | |
| 05.03.21 | BT Group Outperform | Credit Suisse Group | |
| 05.03.21 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 04.03.21 | National Grid Outperform | Credit Suisse Group | |
| 03.03.21 | Prudential Outperform | RBC Capital Markets | |
| 03.03.21 | Prudential Neutral | JP Morgan Chase & Co. | |
| 03.03.21 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 03.03.21 | HSBC buy | Goldman Sachs Group Inc. | |
| 03.03.21 | Shell (ex Royal Dutch Shell) overweight | JP Morgan Chase & Co. | |
| 03.03.21 | BP overweight | JP Morgan Chase & Co. | |
| 03.03.21 | Shell (ex Royal Dutch Shell) overweight | JP Morgan Chase & Co. | |
| 02.03.21 | BAT overweight | JP Morgan Chase & Co. | |
| 02.03.21 | AstraZeneca buy | UBS AG | |
| 02.03.21 | GSK buy | Goldman Sachs Group Inc. | |
| 02.03.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 01.03.21 | Prudential Outperform | RBC Capital Markets | |
| 26.02.21 | BP Outperform | Bernstein Research | |
| 26.02.21 | Shell (ex Royal Dutch Shell) Outperform | Bernstein Research | |
| 26.02.21 | Shell (ex Royal Dutch Shell) Outperform | Bernstein Research | |
| 25.02.21 | AstraZeneca buy | UBS AG | |
| 25.02.21 | Diageo Outperform | Credit Suisse Group | |
| 24.02.21 | Diageo Sector Perform | RBC Capital Markets |
